Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 29 04:00PM ET
15.88
Dollar change
-0.69
Percentage change
-4.16
%
IndexRUT P/E29.49 EPS (ttm)0.54 Insider Own13.97% Shs Outstand107.12M Perf Week-3.93%
Market Cap1.88B Forward P/E12.33 EPS next Y1.29 Insider Trans-1.81% Shs Float101.62M Perf Month4.27%
Income65.12M PEG- EPS next Q0.23 Inst Own74.57% Short Float7.87% Perf Quarter9.07%
Sales411.35M P/S4.56 EPS this Y49.52% Inst Trans9.06% Short Ratio6.09 Perf Half Y12.62%
Book/sh4.76 P/B3.34 EPS next Y36.73% ROA12.36% Short Interest7.99M Perf Year38.09%
Cash/sh2.63 P/C6.04 EPS next 5Y- ROE14.55% 52W Range11.09 - 17.50 Perf YTD-5.53%
Dividend Est.- P/FCF14.76 EPS past 5Y- ROI11.54% 52W High-9.23% Beta0.73
Dividend TTM- Quick Ratio4.83 Sales past 5Y4106.79% Gross Margin78.14% 52W Low43.19% ATR (14)0.57
Dividend Ex-Date- Current Ratio5.09 EPS Y/Y TTM-37.90% Oper. Margin19.04% RSI (14)49.98 Volatility2.95% 3.51%
Employees167 Debt/Eq0.01 Sales Y/Y TTM60.38% Profit Margin15.83% Recom1.00 Target Price27.29
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q-27.29% Payout0.00% Rel Volume0.64 Prev Close16.57
Sales Surprise-0.34% EPS Surprise-4.19% Sales Q/Q15.40% EarningsMay 08 AMC Avg Volume1.31M Price15.88
SMA200.30% SMA501.23% SMA20010.04% Trades Volume839,835 Change-4.16%
Date Action Analyst Rating Change Price Target Change
Mar-14-24Initiated Citigroup Buy $27
Mar-07-24Initiated BofA Securities Buy $23
Dec-21-23Initiated Oppenheimer Outperform $30
Aug-24-22Downgrade ROTH Capital Buy → Neutral $10 → $15.50
Sep-21-18Initiated Cantor Fitzgerald Overweight
Sep-07-18Resumed Piper Jaffray Overweight
Oct-05-16Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16Downgrade Piper Jaffray Overweight → Neutral $6 → $1
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
May-28-24 08:03AM
May-15-24 08:00AM
May-10-24 05:20PM
May-09-24 11:40AM
May-08-24 05:04PM
04:16PM Loading…
04:16PM
May-01-24 10:01AM
08:00AM
Apr-25-24 01:00AM
Apr-24-24 01:45PM
Apr-22-24 08:00AM
Apr-13-24 12:18PM
Mar-29-24 11:30AM
Mar-28-24 08:03AM
Mar-27-24 08:03AM
07:44AM Loading…
07:44AM
Mar-18-24 08:01PM
Mar-14-24 02:00AM
Mar-13-24 07:55AM
Mar-10-24 03:24PM
Mar-05-24 08:03AM
Feb-29-24 12:10PM
Feb-28-24 07:20PM
06:35PM
06:03PM
Feb-27-24 08:03AM
Feb-21-24 09:00AM
Feb-14-24 08:03AM
Jan-18-24 09:50AM
04:54AM
08:45AM Loading…
Jan-15-24 08:45AM
Jan-14-24 08:40AM
Jan-12-24 09:45AM
Jan-09-24 04:57PM
04:05PM
Jan-08-24 08:55AM
Jan-05-24 08:02AM
Jan-04-24 04:49PM
Dec-18-23 06:30AM
Dec-17-23 12:03PM
Dec-08-23 11:30AM
Dec-05-23 08:03AM
Dec-04-23 08:03AM
Nov-16-23 08:05AM
Nov-09-23 06:10AM
Nov-08-23 04:11PM
Nov-02-23 10:37AM
10:00AM
Nov-01-23 10:01AM
Oct-30-23 08:03AM
Oct-26-23 03:19PM
Oct-23-23 08:03AM
Oct-19-23 08:03AM
Oct-16-23 08:03AM
Oct-13-23 08:03AM
Oct-12-23 09:50AM
09:40AM
Sep-18-23 08:03AM
Sep-08-23 11:30AM
Sep-06-23 01:06PM
Aug-16-23 10:56AM
Aug-14-23 08:05AM
Aug-11-23 06:09AM
Aug-09-23 05:50PM
04:41PM
04:17PM
Aug-03-23 02:44PM
Jul-25-23 08:03AM
Jul-24-23 08:03AM
Jul-23-23 10:21AM
Jul-19-23 06:00AM
Jul-05-23 05:50PM
Jul-02-23 01:46PM
Jun-29-23 05:50PM
Jun-23-23 05:50PM
Jun-21-23 08:00PM
Jun-20-23 06:00AM
Jun-19-23 09:30AM
Jun-14-23 05:50PM
Jun-09-23 11:30AM
Jun-01-23 09:30AM
08:03AM
May-30-23 08:03AM
May-22-23 08:15AM
May-12-23 09:30AM
May-11-23 08:41AM
May-10-23 05:55PM
04:53PM
04:27PM
May-09-23 08:03AM
May-03-23 05:45PM
May-01-23 08:03AM
Apr-27-23 05:45PM
Apr-26-23 08:00PM
12:45PM
Apr-24-23 05:50PM
08:03AM
Apr-20-23 12:26PM
08:03AM
Apr-18-23 05:50PM
Catalyst Pharmaceuticals, Inc. is a commercial-stage, patient-centric biopharmaceutical company, which focuses on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult to treat diseases. The company was founded by Hubert E. Huckel and Patrick J. McEnany in January 2002 and is headquartered in Coral Gables, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tierney David SDirectorApr 08 '24Option Exercise4.0125,000100,250373,874Apr 10 05:15 PM
Tierney David SDirectorApr 08 '24Sale15.6825,000392,000348,874Apr 10 05:15 PM
Elsbernd BrianChief Compliance/Legal OfficerMar 27 '24Sale16.4425,000411,000124,433Mar 28 04:45 PM
DENKHAUS DONALD ADirectorFeb 05 '24Option Exercise4.0140,000160,400434,333Feb 06 05:00 PM
MCENANY PATRICK JChairman of Board of DirectorsJan 02 '24Option Exercise1.13250,000282,5004,385,256Jan 03 05:19 PM
O'Keeffe Charles BDirectorJan 02 '24Option Exercise1.1360,00067,800681,724Jan 03 05:18 PM
Tierney David SDirectorJan 02 '24Option Exercise1.1310,00011,300344,874Jan 03 05:19 PM
Harper MollyDirectorDec 15 '23Option Exercise5.7810,00057,80010,000Dec 19 05:00 PM
Harper MollyDirectorDec 15 '23Sale14.3914,000201,4200Dec 19 05:00 PM
Tierney David SDirectorDec 12 '23Option Exercise1.1350,00056,500383,541Dec 14 05:00 PM
Tierney David SDirectorDec 12 '23Sale13.3250,000666,250333,541Dec 14 05:00 PM
Miller SteveChief Op. & Scientific OfficerDec 11 '23Option Exercise1.13150,000169,500797,457Dec 13 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 11 '23Option Exercise1.1360,00067,800110,557Dec 12 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 11 '23Sale13.7660,000825,78050,557Dec 12 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 08 '23Option Exercise1.1340,00045,20090,557Dec 12 05:00 PM
GRANDE ALICIAVP, Treasurer and CFODec 08 '23Sale14.2840,000571,00050,557Dec 12 05:00 PM
Daly Richard JDirectorDec 07 '23Option Exercise1.1360,00067,800208,000Dec 11 05:00 PM
INGENITO GARYChief Med. & Reg. OfficerDec 06 '23Option Exercise1.1350,00056,50088,367Dec 08 05:00 PM
INGENITO GARYChief Med. & Reg. OfficerDec 06 '23Sale14.0250,000701,00038,367Dec 08 05:00 PM
Miller SteveChief Op. & Scientific OfficerDec 05 '23Sale14.2440,000569,600647,457Dec 07 05:00 PM
DENKHAUS DONALD ADirectorAug 03 '23Option Exercise1.1360,00067,800393,000Aug 04 05:00 PM